Stay updated on Amivantamab Combo Therapy Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo Therapy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for the PAPILLON study is now displayed, describing its comparison of amivantamab plus chemotherapy with chemotherapy alone for advanced or metastatic EGFR exon 20 insertion non-small cell lung cancer. The record also includes participant criteria, outcome measures, locations, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-08T09:51:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0. The study record remains unavailable on the page.
    Difference
    0.2%
    Check dated 2026-11-01T11:24:16.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates about a terminology transition, saying NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T11:32:26.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T11:59:33.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The 403 Forbidden page’s footer revision label changes from v3.7.0 to v3.7.1, while the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-11T13:33:52.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record content. The displayed message appears as an access-denied page with the site's header and footer visible.
    Difference
    16%
    Check dated 2026-09-20T08:23:54.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo Therapy Clinical Trial page.